Loading
Latest filing published 20 Jun 2019 for Selectimmune Pharma AB. Read the official filing
No signal scores available.
All filings by Erik Sturegård on record concern Selectimmune Pharma AB. We count 2 filings, every one of them for a trade on 20 June 2019.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 20 June 2019, reports a transaction in Selectimmune Pharma AB. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations